Searched for
EVEROLIMUS TABLETS
Biocon arm gets USFDA nod for generic Everolimus tabletsBiocon's arm, Biocon Pharma Ltd, has secured USFDA approval for its generic Everolimus tablets. This medication aids in treating tuberous s...- Biocon plans $150-million capex in two yearsBiocon plans a $150 million capital expenditure, allocating $100 million to biologics, primarily enhancing Malaysian capacities, and $50 mi...
- Biocon Q3 Results: Net profit rises 11% YoY to Rs 187 croreThe earnings before interest, tax depreciation and amortisation (EBITDA) rose 25% YoY to Rs 537 crore. The EBITDA margins for the third qua...
- Stocks in the news: RIL, DMart, ZEEL, Federal Bank, NTPC and BSEReliance Industries has incorporated a new subsidiary in the UAE for trading in crude oil, petroleum products and agricultural commodities.
- Natco Pharma gets American drug regulator's nod for generic cancer treatment drugNatco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...
- Natco's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc (BPI) has received final approval for its abbreviated new drug application (ANDA) for Everolimus tablets f...
- Natco pharma's US partner files Abbreviated New Drug Application for EverolimusThe drug, used to prevent organ rejection after a kidney or liver transplant, generated sales of $43.5 mn for the 12-mth period ending July.
Load More